Price $8.85 |
Market Cap
478.9M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
2.7
|
P/B
1.11
|
P/S
1.12
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
3.1
|
Op. Cash Flow
164.8K
|
FCF
2.4
|
|
Op. Margin
41.90%
|
Net Margin
41.60%
|
ROE
46.70%
|
ROI
24.30%
|
|
ROA
34.60%
|
EPS Growth
168.70%
|
Current Ratio
5.7
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Harvard Bioscience, Inc. (HBIO) | $3.70 | - | - | 183.6M | Strong Buy |
| Chromadex Corp (CDXC) | $3.69 | - | - | 105.8M | Strong Buy |
| Cidara Therapeutics Inc (CDTX) | $0.68 | - | - | 78M | Strong Buy |
| Sonoma Pharmaceuticals Inc (SNOA) | $0.15 | - | - | 2.3M | Strong Buy |
| Spruce Biosciences Inc (SPRB) | $0.70 | - | - | 45.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
